European Archives - Page 405 of 899 - European Medical Journal

26th October 2020

COVID-19 Delays Could Have a Profound Impact on Breast Cancer Outlook

DELAYS in treatment, as a result of the coronavirus disease (COVID-19) pandemic, have been experienced by many people with cancer across the world.

26th October 2020

Male Sex May Be the Defining Factor in Predicting Susceptibility to and Severity of SARS-CoV-2 Infection: A Case Series

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus that causes the coronavirus disease (COVID-19)…

23rd October 2020

One in Five Patients Undergoing Major Surgery Develop Heart Complications

Major noncardiac surgery leads to development of one or more heart complications within a year for one in five patients.

23rd October 2020

Low Risk of Moderate or Severe COVID-19 in Congenital Heart Disease

SARS-CoV-2 infection in patients with congenital heart disease (CHD) is associated with a low risk of moderate or severe coronavirus disease

23rd October 2020

EMJ Podcast: The Slower Moving Pandemic

Jonathan chats to Professor Sabiha Essack, Research Chair in Antibiotic Resistance and One Health, University of KwaZulu-Natal.

EMJ Nephrology [Supplement 4] 2020 Feature Image

23rd October 2020

Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: From Diagnosis to Outcomes

AAV encompasses a rare group of severe, progressive autoimmune diseases that involve a necrotising vasculitis and can affect many vital organs including…

EMJ Nephrology [Supplement 4] 2020 Feature Image

EMJ Nephrology 8 [Supplement 4] 2020

“ANTI-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitis: From Diagnosis to Outcomes,” reviews posters presented at…

23rd October 2020

ESC Congress 2020: Overview of Updated Heart Failure Trials and Promising Drugs

The ESC Congress 2020 presented several promising clinical trials that may potentially change our practice in heart failure management.

Talking to Ian Dorrian

Ian Dorrian, President Communications Europe, Syneos Health, talks about his journey from the pharmaceutical industry to the agency world, what pharma can do to mitigate the spread of fake news, and how long-term use of virtual communication could affect product launches of the future.

20th October 2020

Empowering Physicians to Advance the Future of Alzheimer’s Disease Management and Care

First presented at the Alzheimer’s Association International Conference® (AAIC®) 2020 virtual event, this symposium covered the need for early diagnosis of AD to enable refined care